TAMPA, Fla., Sep. 3, 2015. OTC, HCRE, /PRNewswire/ — HemCare Health Services, Inc. (OTC; HCRE) – HemCare Health Services has signed a binding letter of intent to acquire 95% of John Isaac Delgado, M.D., P.A.
The acquisition will provide HemCare with access to over 200 insurance agreements from various national PPO and HMO insurance providers. The concept is referred to as a single member EIN, and is very common with large multi-location medical offices.
HemCare’s CEO James Cao commented “Many insurance providers no longer offer open registration to new medical clinics. This purchase will permit every new HemCare clinic opened in the United States the ability to immediately accept and bill those insurance providers for services rendered. This is accomplished through a Management Services Organization agreement with each new HemCare franchise location.”
On May 19, 2015 the Company announced it had licensed the perpetual rights to use Ultroid Marketing Development Corp’s products and the trade name “Ultroid System”. The rights will allow the Company to enter into a clinical treatment of Hemorrhoidal Maladies. Amongst several other attributes, the Products are non-invasive and provide fast and effective relief in the treatment of Hemorrhoids.
HemCare will acquire the controlling interest through the issuance of 2,000,000 restricted common shares. Management expects to conclude the acquisition following due diligence and an audit of the business.
HemCare Health Services, Inc. (HCRE) is a public health care and technology company. The company’s mission is to become an integrated provider of systems to treat and cure Hemorrhoidal Disease through franchising a successful clinical model and use of proprietary devices.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. Additional information respecting the factors that could materially affect the Company and its operations are contained in its annual report on Form 10K and Form 10-Q as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publically update or revise any forward-looking statement.
Contact: James Cao, President, +1-844-443-6227
SOURCE HemCare Health Services, Inc.